Villoglandular adenocarcinoma of the uterine cervix (AVG): report of an “in situ” case and an analysis of the challenges for cytological diagnosis
DOI:
https://doi.org/10.5327/2237-4574-141%20Keywords:
uterine cervical neoplasms, adenocarcinomas, cytologyAbstract
Villoglandular adenocarcinoma (VGA) is a rare type of cancer that affects the uterine cervix. Early diagnosis can help preserve fertility, since this neoplasm is rarely associated with lymphovascular invasion. Its cytological diagnosis is challenging, since the cytomorphological criteria are considered subtle when compared to other types of adenocarcinomas, which can lead to underdiagnosis. Another difficulty is its similarity to other entities, benign or malignant, that can simulate it. Understanding its characteristics helps to increase the potential of cytology as an effective auxiliary tool in the diagnosis of this disease.
References
Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância. Controle do câncer do colo do útero no Brasil: dados e números: 2025. Rio de Janeiro: INCA, 2025 [acessado em 13 jan. 2025]. Disponível em: https://www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controle-do-cancer-do-colo-do-utero/dados-e-numeros
Korach J, Machtinger R, Perri T, Vicus D, Segal J, Fridman E, et al. Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge. Acta Obstet Gynecol Scand. 2009;88(3):355-8. https://doi.org/10.1080/00016340902730359
Saida T, Sakata A, Tanaka YO, Ochi H, Ishiguro T, Sakai M, et al. Clinical and MRI characteristics of the uterine cervical adenocarcinoma: its variants and mimics. Korean J Radiol. 2019;20(3):364-77. https://doi.org/10.3348/kjr.2018.0458
Gonçalves MAG, Anschau F, Marc C, Meurer L. Adenocarcinoma viloglandular da cérvice uterina. Rev Bras Ginecol Obstet. 2007;29(11):575-9. https://doi.org/10.1590/S0100-72032007001100005
Choi Y, Kim H, Choi H, Hwang D, Choe G, Chung JH, et al. Liquid-based cytology of villoglandular adenocarcinoma of the cervix: a report of 3 cases. Korean J Pathol. 2012;46(2):215-20. https://doi.org/10.4132/KoreanJPathol.2012.46.2.215
Giannella L, Di Giusepe J, Carpini GD, Grelloni C, Fichera M, Sartini G, et al. HPV-negative adenocarcinomas of the uterine cervix: from molecular characterization to clinical implications. Int J Mol Sci. 2022;23(23):15022. https://doi.org/10.3390/ijms232315022
Liu X, Hou C. Cervical villoglandular adenocarcinoma: a rare case report and review of literature. Eur J Gynaecol Oncol. 2022;43(3):152-6. https://doi.org/10.22514/ejgo.2022.020
Guo P, Liu P, Yang J, Ren T, Xiang Y. Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome. Cancer Manag Res. 2018;10:3955-61. https://doi.org/10.2147/CMAR.SI658I7
Ballo MS, Silverberg SG, Sidawy MK. Cytologic features of well-differentiated villoglandular adenocarcinoma of the cervix. Acta Cytol. 1996;40(3):536-40. https://doi.org/10.1159/000333911
Findik S, Görkemli H. Villoglandulary papillary adenocarcinoma co-existing with high-grade squamous intraepitelial lesion; arising from an endocervical polyp. Eur J Gen Med. 2017;14(4):119-21. https://doi.org/10.29333/ejgm/81745
Stolnicu S, Brito MJ, Karpathiou G, Hoang L, Felix A, Matoiu C, et al. Villoglandular pattern in HPV-associated endocervical adenocarcinoma is associated with excellent prognosis: a reappraisal of 31 cases using IECC and Silva Pattern Classification. Int J Gynecol Pathol. 2023;42(3):270-7. https://doi.org/10.1097/PGP.0000000000000916
Hagiwara T, Kaku T, Kobayashi H, Wake N, Saito T. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: assessment of cytological features by histological subtypes. Acta Cytol. 2013;57(1):61-8. https://doi.org/10.1159/000342917
Novotny DB, Ferlisi P. Villoglandular adenocarcinoma of the cervix: cytologic presentation. Diagn Cytopathol. 1997;17(5):383-7. https://doi.org/10.1002/(sici)1097-0339(199711)17:5<383::aid-dc13>3.0.co;2-j
